CME Group (NASDAQ:CME – Get Free Report) had its price target hoisted by investment analysts at Royal Bank of Canada from $235.00 to $269.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “sector perform” rating on the financial services provider’s stock. Royal Bank of Canada’s price objective suggests a potential upside of 9.58% from the stock’s current price.
Other equities research analysts also recently issued research reports about the company. Oppenheimer boosted their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. JPMorgan Chase & Co. upped their target price on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research report on Thursday. Keefe, Bruyette & Woods decreased their target price on CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a research report on Monday, January 13th. Finally, Piper Sandler upped their target price on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $234.13.
Get Our Latest Stock Report on CME
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.39% and a net margin of 57.34%. As a group, research analysts predict that CME Group will post 10.18 EPS for the current year.
CME Group announced that its Board of Directors has initiated a stock buyback plan on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.
Insider Buying and Selling at CME Group
In other news, insider Julie Winkler sold 11,592 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.30% of the stock is currently owned by insiders.
Institutional Trading of CME Group
Institutional investors and hedge funds have recently made changes to their positions in the stock. Truvestments Capital LLC acquired a new stake in shares of CME Group during the 3rd quarter worth approximately $26,000. SJS Investment Consulting Inc. raised its position in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the period. Dunhill Financial LLC raised its position in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares during the period. New Age Alpha Advisors LLC raised its position in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the period. Finally, Financial Life Planners acquired a new stake in shares of CME Group during the 4th quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- What Are Trending Stocks? Trending Stocks Explained
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Compound Interest and Why It Matters When Investing
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.